Back to Oxytocin research
oxytocin 2026-05-12 PubMed

FOXP1 differentially regulates murine vasopressin and oxytocin neuron development, disproportionately affecting OXT neurons

FOXP1 is differentially active during development of murine vasopressin and oxytocin magnocellular neurons.

Background

Hypothalamic arginine vasopressin (AVP) and oxytocin (OXT) magnocellular neurons (MCNs) are vital for fluid balance, social behavior, and stress response. Despite sharing a common developmental lineage, the specific transcription factors driving their distinct specification remain largely unknown. Understanding these developmental pathways is critical for addressing conditions linked to AVP or OXT dysregulation, such as diabetes insipidus or autism spectrum disorders. This study aimed to identify key transcriptional regulators involved in the differential development of these crucial neuron populations.

Study Design

Researchers employed a multi-modal approach, beginning with gene regulatory network analysis on published single-cell RNA-sequencing data from the developing mouse hypothalamus. This identified candidate transcription factors for differential MCN specification. They then used computational cell fate mapping to model developmental gene expression dynamics. Further, in silico analysis predicted binding sites for specific factors on Avp and Oxt promoters. An in vitro reporter assay was used to validate these regulatory interactions. Finally, heterozygous FOXP1 knockout mice were generated and analyzed to assess the in vivo role of FOXP1 in AVP and OXT neuron abundance.

Results

Gene regulatory network analysis identified RORA, EBF3, FOXP1, FOXP2, and BCL11B as candidate transcription factors. Computational cell fate mapping revealed enrichment of EBF3 and BCL11B in the Avp lineage, while FOXP1 and FOXP2 were enriched in the Oxt lineage. In silico analysis predicted binding sites for FOXP1 and FOXP2 on both Avp and Oxt genomic promoters, which was subsequently confirmed by an in vitro reporter assay demonstrating their regulatory activity. The most significant finding came from genetic manipulation:

Heterozygous FOXP1 knockout mice exhibited a significant reduction in both AVP and OXT neuron abundance. Importantly, OXT neurons were disproportionally affected compared to AVP neurons in these knockout animals. This indicates a critical and differential role for FOXP1 in MCN development.

Key Findings

  • EBF3 and BCL11B were enriched in the Avp lineage, while FOXP1 and FOXP2 were enriched in the Oxt lineage.
  • FOXP1 and FOXP2 binding sites were predicted on Avp and Oxt promoters and confirmed by in vitro reporter assay.
  • Heterozygous FOXP1 knockout mice showed a significant reduction in both AVP and OXT neuron abundance.
  • OXT neurons were disproportionally affected in FOXP1 knockout mice compared to AVP neurons.

Why It Matters

This research provides fundamental insights into the neurodevelopmental programming of AVP and OXT neurons, identifying FOXP1 as a key transcription factor. Understanding these early developmental mechanisms could pave the way for future therapeutic strategies targeting conditions characterized by AVP or OXT deficiencies or imbalances. Identifying FOXP1's differential role suggests that interventions could potentially be tailored to selectively modulate OXT or AVP neuron populations, rather than broadly affecting both. While this is foundational preclinical work, it highlights a novel target for investigating developmental origins of neuroendocrine disorders and could inform future research into peptide-based therapies or genetic interventions.


oxytocin foxp1 vasopressin oxytocin neurodevelopment hypothalamus transcription-factor
Source: pubmed:42088346 · Ingested 2026-05-12 · Digest: gemini-2.5-flash